The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Chronic forms of depression have been closely studied over the last three decades, and it is now widely recognized that these conditions are better classified under the umbrella of affective disorders rather than characterological or personality disorders. Chronic depressive disorders include dysthymic disorder, chronic major depressive episode, major depressive episode superimposed on dysthymic disorder (double depression), as well as recurrent major depressive disorder without full interepisode recovery. Chronic forms of depression are prevalent in the general population, and even those with low grade severity can lead to significant functional impairment, occupational dysfunction, suicide attempts, and worse prognosis. Given the obvious potential for deleterious effects, chronic forms of depression should be promptly recognized and aggressively treated. Clinical benefit from using psychopharmacologic agents alone or in combination with psychotherapy for the treatment of chronic depression has been demonstrated. In this article the authors review pertinent clinical and diagnostic aspects in chronic depressive disorders as well as their treatment.